Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Scientists devise new route to synthesize insecticide in 15 steps

Scientists devise new route to synthesize insecticide in 15 steps

Stiff arteries can negatively impact memory and vital brain processes

Stiff arteries can negatively impact memory and vital brain processes

Western dietary pattern linked to risk of developing Alzheimer's disease

Western dietary pattern linked to risk of developing Alzheimer's disease

People with high levels of four biomarkers may have increased risk for stroke

People with high levels of four biomarkers may have increased risk for stroke

Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Advances in brain research since patient HM: an interview with Dr Jacopo Annese

Advances in brain research since patient HM: an interview with Dr Jacopo Annese

Avoiding foods high in AGEs could help protect from developing diabetes

Avoiding foods high in AGEs could help protect from developing diabetes

Research supports potential role for cognitive activity in prevention of Alzheimer's disease

Research supports potential role for cognitive activity in prevention of Alzheimer's disease

HMS study reveals key instigator of nerve cell damage in ALS patients

HMS study reveals key instigator of nerve cell damage in ALS patients

Multivariate approach helps improve MMSE test for Alzheimer's disease

Multivariate approach helps improve MMSE test for Alzheimer's disease

Novel scaffolds may open new avenues in stem and cancer cell manipulation

Novel scaffolds may open new avenues in stem and cancer cell manipulation

New MRI method detects low zinc levels to help identify healthy prostate tissue from cancer

New MRI method detects low zinc levels to help identify healthy prostate tissue from cancer

Salk researchers identify new mechanism for Alzheimer's risk gene

Salk researchers identify new mechanism for Alzheimer's risk gene

MGH investigators discover key molecules essential for sensing proteasome dysfunction

MGH investigators discover key molecules essential for sensing proteasome dysfunction

Healthy BMI, exercise and diet can lower abnormal protein build-ups linked to Alzheimer’s

Healthy BMI, exercise and diet can lower abnormal protein build-ups linked to Alzheimer’s

Drugs designed to target nervous system could control inflammation in the gut, study shows

Drugs designed to target nervous system could control inflammation in the gut, study shows

Commonly used anti-inflammatory drug shows potential to treat Alzheimer's disease

Commonly used anti-inflammatory drug shows potential to treat Alzheimer's disease

Novel PET radiotracer reveals epigenetic activity in the human brain for the first time

Novel PET radiotracer reveals epigenetic activity in the human brain for the first time

Early treatment of multiple sclerosis may offer long-lasting effect on disease activity

Early treatment of multiple sclerosis may offer long-lasting effect on disease activity

Easy-to-test clinical markers may help identify people at risk for age-related neurological diseases

Easy-to-test clinical markers may help identify people at risk for age-related neurological diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.